Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Mark

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Neurologic Clinics|September 5, 2001
Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degenerationM H Mark
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Levodopa-associated hemifacial dystoniaM H Mark, J I Sage
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1994
Parkinson's disease and depression: the relationship to disability and personalityM A Menza, M H Mark
Annals of Clinical and Laboratory Science|January 1, 1994
An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesiasM H Mark, J I Sage
Annals of Neurology|January 1, 1995
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profileJ I Sage, M H Mark
Journal of General Internal Medicine|October 1, 1994
Diagnosis and treatment of Parkinson's disease in the elderlyJ I Sage, M H Mark
Neurology|January 1, 1992
The rationale for continuous dopaminergic stimulation in patients with Parkinson's diseaseJ I Sage, M H Mark
Annals of Clinical and Laboratory Science|March 1, 1989
Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's diseaseM H Mark, J I Sage
Annals of Clinical and Laboratory Science|November 1, 1989
Long-term efficacy of controlled-release carbidopa/levodopa in patients with advanced Parkinson's diseaseM H Mark, J I Sage
Annals of Clinical and Laboratory Science|November 1, 1984
The human subfornical organ: an anatomic and ultrastructural studyM H Mark, P M Farmer
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Neurologic Clinics|September 5, 2001
Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degenerationM H Mark
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Levodopa-associated hemifacial dystoniaM H Mark, J I Sage
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1994
Parkinson's disease and depression: the relationship to disability and personalityM A Menza, M H Mark
Annals of Clinical and Laboratory Science|January 1, 1994
An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesiasM H Mark, J I Sage
Annals of Neurology|January 1, 1995
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profileJ I Sage, M H Mark
Journal of General Internal Medicine|October 1, 1994
Diagnosis and treatment of Parkinson's disease in the elderlyJ I Sage, M H Mark
Neurology|January 1, 1992
The rationale for continuous dopaminergic stimulation in patients with Parkinson's diseaseJ I Sage, M H Mark
Annals of Clinical and Laboratory Science|March 1, 1989
Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's diseaseM H Mark, J I Sage
Annals of Clinical and Laboratory Science|November 1, 1989
Long-term efficacy of controlled-release carbidopa/levodopa in patients with advanced Parkinson's diseaseM H Mark, J I Sage
Annals of Clinical and Laboratory Science|November 1, 1984
The human subfornical organ: an anatomic and ultrastructural studyM H Mark, P M Farmer
Pageof 5